BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9821175)

  • 1. Quantitative determination of K-ras mutations in pancreatic juice for diagnosis of pancreatic cancer using hybridization protection assay.
    Watanabe H; Yamaguchi Y; Ha A; Hu YX; Motoo Y; Okai T; Yoshimura T; Sawabu N
    Pancreas; 1998 Nov; 17(4):341-7. PubMed ID: 9821175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of supernatant of pancreatic juice for genetic analysis of K-ras in diagnosis of pancreatic carcinoma.
    Ha A; Watanabe H; Yamaguchi Y; Ohtsubo K; Wang Y; Motoo Y; Okai T; Wakabayahi T; Sawabu N
    Pancreas; 2001 Nov; 23(4):356-63. PubMed ID: 11668203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K-ras mutations in duodenal aspirate without secretin stimulation for screening of pancreatic and biliary tract carcinoma.
    Watanabe H; Ha A; Hu YX; Ohtsubo K; Yamaguchi Y; Motoo Y; Okai T; Toya D; Tanaka N; Sawabu N
    Cancer; 1999 Oct; 86(8):1441-8. PubMed ID: 10526271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum tumor markers and molecular biological diagnosis in pancreatic cancer.
    Sawabu N; Watanabe H; Yamaguchi Y; Ohtsubo K; Motoo Y
    Pancreas; 2004 Apr; 28(3):263-7. PubMed ID: 15084968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of K-ras point mutations at codon 12 in pure pancreatic juice for the diagnosis of pancreatic cancer by PCR-RFLP analysis.
    Watanabe H; Sawabu N; Songür Y; Yamaguchi Y; Yamakawa O; Satomura Y; Ohta H; Motoo Y; Okai T; Wakabayashi T
    Pancreas; 1996 Jan; 12(1):18-24. PubMed ID: 8927616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of K-ras point mutations at codon 12 in pancreatic juice for the diagnosis of pancreatic cancer by hybridization protection assay: a simple method for the determination of the types of point mutation.
    Watanabe H; Miyagi C; Yamaguchi Y; Satomura Y; Ohta H; Motoo Y; Okai T; Yoshimura T; Tsuji Y; Sawabu N
    Jpn J Cancer Res; 1996 May; 87(5):466-74. PubMed ID: 8641983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of p53 gene mutations in the supernatant of pancreatic juice and plasma from patients with pancreatic carcinomas.
    Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Motoo Y; Sawabu N
    Pancreas; 2004 Jan; 28(1):13-9. PubMed ID: 14707724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant methylation of secreted apoptosis-related protein 2 (SARP2) in pure pancreatic juice in diagnosis of pancreatic neoplasms.
    Watanabe H; Okada G; Ohtsubo K; Yao F; Jiang PH; Mouri H; Wakabayashi T; Sawabu N
    Pancreas; 2006 May; 32(4):382-9. PubMed ID: 16670620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma.
    Jiang P; Watanabe H; Okada G; Ohtsubo K; Mouri H; Tsuchiyama T; Yao F; Sawabu N
    Cancer Sci; 2006 Nov; 97(11):1267-73. PubMed ID: 16965396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preproenkephalin hypermethylation in the pure pancreatic juice compared with p53 mutation in the diagnosis of pancreatic carcinoma.
    Ohtsubo K; Watanabe H; Yao F; Okada G; Mouri H; Yamaguchi Y; Sawabu N
    J Gastroenterol; 2006 Aug; 41(8):791-7. PubMed ID: 16988769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of K-ras oncogene mutations in the pure pancreatic juice of patients with ductal pancreatic cancers.
    Watanabe H; Sawabu N; Ohta H; Satomura Y; Yamakawa O; Motoo Y; Okai T; Takahashi H; Wakabayashi T
    Jpn J Cancer Res; 1993 Sep; 84(9):961-5. PubMed ID: 8407563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of mutations of p53 tumor suppressor gene in pancreatic juice and its application to diagnosis of patients with pancreatic cancer: comparison with K-ras mutation.
    Yamaguchi Y; Watanabe H; Yrdiran S; Ohtsubo K; Motoo Y; Okai T; Sawabu N
    Clin Cancer Res; 1999 May; 5(5):1147-53. PubMed ID: 10353750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutation of the K-ras oncogene in pancreatic carcinoma, and application of its detection in pancreatic juice to diagnose pancreatic carcinoma].
    Sawabu N; Watanabe H; Yamaguchi Y; Okai T
    Nihon Rinsho; 1995 Feb; 53(2):511-7. PubMed ID: 7699881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of mesothelin mRNA in pure pancreatic juice from patients with pancreatic carcinoma, intraductal papillary mucinous neoplasm of the pancreas, and chronic pancreatitis.
    Watanabe H; Okada G; Ohtsubo K; Yamaguchi Y; Mouri H; Motoo Y; Wakabayashi T; Sawabu N
    Pancreas; 2005 May; 30(4):349-54. PubMed ID: 15841046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical usefulness of tumor markers associated with pancreatic cancer].
    Watanabe H; Kawakami H; Yamakawa O; Satomura Y; Ohta H; Motoo Y; Okai T; Sawabu N
    Rinsho Byori; 1994 Feb; 42(2):127-38. PubMed ID: 7908065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma.
    Kondo H; Sugano K; Fukayama N; Kyogoku A; Nose H; Shimada K; Ohkura H; Ohtsu A; Yoshida S; Shimosato Y
    Cancer; 1994 Mar; 73(6):1589-94. PubMed ID: 8156485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of c-Ki-ras point mutation from pancreatic juice. A useful diagnostic approach for pancreatic carcinoma.
    Miki H; Matsumoto S; Harada H; Mori S; Haba R; Ochi K; Kobayashi S; Ohmori M
    Int J Pancreatol; 1993 Oct; 14(2):145-8. PubMed ID: 8283078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical usefulness of K-ras gene mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancer.
    Boadas J; Mora J; Urgell E; Puig P; Roca M; Cussó X; Capellà G; Lluís F; Farré A
    Eur J Gastroenterol Hepatol; 2001 Oct; 13(10):1153-9. PubMed ID: 11711770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of K-ras mutation and CEA level in pancreatic juice in the diagnosis of pancreatic cancer.
    Futakawa N; Kimura W; Yamagata S; Zhao B; Ilsoo H; Inoue T; Sata N; Kawaguchi Y; Kubota Y; Muto T
    J Hepatobiliary Pancreat Surg; 2000; 7(1):63-71. PubMed ID: 10982594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-step enriched-nested PCR technique enhances sensitivity for detection of codon 12 K-ras mutations in pancreatic adenocarcinoma.
    Banerjee SK; Makdisi WF; Weston AP; Campbell DR
    Pancreas; 1997 Jul; 15(1):16-24. PubMed ID: 9211488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.